tirzepatide and hashimoto's disease – Josey Medical Clinic: Family Doctors Tirzepatide for Hashimoto's: Benefits, Risks

Obesity is known to increase the risk of at least 13 different types of cancer so reducing body weight would almost certainly reduce ones risk for those particular cancers, he said.

Updated on April 30th, 2026 Both medications target dual GLP-1/GIP receptors, but only Tirzepatide has FDA approval and is available by prescriptionSurvodutide remains restricted to clinical trial participants

I hate it to be used the way it's being used," he said

Hair loss is not listed as a common side effect in major clinical studies

Its multifaceted approach, including appetite suppression and slowed gastric emptying, has been shown to result in significant reductions in body fat